Roivant Sciences Ltd. (ROIV)

Roivant Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 6, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	11,110	7,200	8,494	5,597	3,419	502
Market Cap Growth	25.20%	-15.23%	51.75%	63.72%	580.90%	-
Enterprise Value	6,755	2,500	2,824	5,021	1,886	-326
Last Close Price	16.17	10.09	10.54	7.38	4.94	9.78
PE Ratio	-	-	1.95	-	-	-
PS Ratio	480.28	247.81	259.64	177.52	61.84	21.10
PB Ratio	2.54	1.39	1.32	3.48	1.66	0.24
P/TBV Ratio	2.57	1.54	1.42	5.53	2.06	0.28
EV/Sales Ratio	290.74	86.05	86.33	159.25	34.11	-
Debt / Equity Ratio	0.02	0.02	0.01	0.30	0.14	0.12
Asset Turnover	0.00	0.01	0.01	0.01	0.02	0.01
Quick Ratio	39.55	32.71	24.35	6.29	11.21	9.39
Current Ratio	40.54	33.47	25.24	6.60	11.64	9.99
Return on Equity (ROE)	-18.15%	-12.54%	112.87%	-48.46%	-44.82%	-43.17%
Return on Assets (ROA)	-12.59%	-10.73%	-10.14%	-20.33%	-20.26%	-11.71%
Return on Capital (ROIC)	-12.97%	-11.52%	-11.34%	-22.80%	-22.54%	-12.91%
Earnings Yield	-4.40%	-2.39%	51.20%	-18.03%	-24.72%	-161.17%
FCF Yield	-7.70%	-11.72%	-9.03%	-15.29%	-20.33%	-111.12%
Buyback Yield / Dilution	14.95%	12.71%	-16.59%	-6.43%	-6.30%	-187.64%

Updated Aug 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q